BiotechTube
Home/ITB Med/Kellie Calderon
KC

Kellie Calderon

Vice President, Medical Strategy

ITB Med

Therapeutic Areas

TransplantationAutoimmunity

ITB Med Pipeline

DrugIndicationPhase
TCD601 for Kidney ToleranceKidney TransplantationPhase 2
TCD601 for Kidney InductionKidney TransplantationPhase 2
TCD601 for Type-1 DiabetesType-1 Diabetes (New-onset remission)Phase 2
TCD601 for ALSAmyotrophic Lateral SclerosisPhase 2
TCD601 for Liver ToleranceLiver Transplantation (non-autoimmune)Phase 1
TCD601 for GVHD PreventionBone Marrow TransplantationPhase 1

Leadership Team at ITB Med

ML
Matthew Lamb
Chief Executive Officer (Interim)
LZ
Leslie Zacks
Chief Legal and Compliance Officer
KG
Kasper Granlund
Chief Financial Officer
View full ITB Med profile